Drug intelligence / Profile preview

antrodin c

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral, Intravenous, Intraperitoneal
01

Overview

Antrodin C is a bioactive maleimide derivative isolated from the medicinal fungus *Antrodia cinnamomea* (also known as *Antrodia camphorata*). It is primarily investigated for its potent anti-inflammatory and neuroprotective properties, particularly in the context of neurodegenerative diseases. In preclinical models of Alzheimer's disease, Antrodin C has demonstrated the ability to significantly reduce amyloid-beta (Aβ) plaque accumulation and glial cell activation. Its therapeutic potential is attributed to its capacity to modulate microglia morphology and enhance the perivascular clearance of Aβ deposits. Additionally, it has been shown to regulate oxidative enzymes in plaque-associated microglia, suggesting a multi-faceted approach to mitigating neurodegeneration and improving cognitive-related behaviors such as nesting.

Other names
3-isobutyl-4-[4-(3-methyl-2-butenyloxy)phenyl]-1H-pyrrole-2,5-dioneAntrodin C
02

Targets

NF-κBAβ (Amyloid-beta peptides and aggregates)

Beyond the preview

Go deeper on antrodin c.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on antrodin c.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call